Patent US4407805A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4407805A Expired / Lapsed US ⏱️ 0.0 years remaining

Analgesic mixture of nalbuphine and zomepirac

Assignee: EIDP Inc
•
Filing: 1982-06-30
•
Granted: 1983-10-04
•
Expires: 2002-06-30
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Pharmaceutical compositions of nalbuphine and zomepirac have been found to exhibit unexpectedly enhanced analgesic activity by applying an analysis model which considers data characterizing the analgesic effect of both the pure components as well as the fixed dose ratio combinations. This synergism enables the use of lower doses of either or both drugs with a concomitant reduction in risk of possible side effects.

Inventors

  • 👤 William K. Schmidt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-27 18:20
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/395; A61K31/435; A61K31/47; A61K31/485

Claims Analysis

Total Claims: 17
Claim 1
Independent Claim 38 words
A pharmaceutical composition comprising a combination of (a) nalbuphine, or a pharmaceutically acceptable salt thereof, and (b) zomepirac, or a pharmaceutically suitable salt thereof, in which the weight ratio of (a):(b) is from about 1:0.02 to about 1:26.
Claim 2
Dependent Claim 38 words
A pharmaceutical composition comprising a combination of (a) nalbuphine, or a pharmaceutically acceptable salt thereof, and (b) zomepirac, or a pharmaceutically suitable salt thereof, in which the weight ratio of (a):(b) is from about 1:0.02 to about 1:26.
Claim 3
Dependent Claim 18 words
The composition of claim 1 wherein the weight ratio of (a):(b) is from about 1:0.02 to about 1:1.5.
Claim 4
Dependent Claim 14 words
The composition of claim 1 wherein the nalbuphine is present as the hydrochloride salt.
Claim 5
Dependent Claim 14 words
The composition of claim 1 wherein the zomepirac is present as the sodium salt.
Claim 6
Dependent Claim 13 words
The composition of claim 1 which contains in addition a suitable pharmaceutical carrier.
Claim 7
Dependent Claim 13 words
The composition of claim 2 which contains in addition a suitable pharmaceutical carrier.
Claim 8
Dependent Claim 13 words
The composition of claim 3 which contains in addition a suitable pharmaceutical carrier.
Claim 9
Dependent Claim 13 words
The composition of claim 4 which contains in addition a suitable pharmaceutical carrier.
Claim 10
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 1.
Claim 11
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 2.
Claim 12
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 3.
Claim 13
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 4.
Claim 14
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 5.
Claim 15
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 6.
Claim 16
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 7.
Claim 17
Dependent Claim 27 words
A method of alleviating pain in a mammal which comprises administering to said mammal affected with pain an effective analgesic amount of the composition of claim 8.

References Cited (Backward Citations)

US3393197A Cited
US4132788A Cited
US4237140A Cited
US4282215A Cited
US4322427A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-10-03 1987-04-04 1987-10-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-10-03 1991-04-04 1991-10-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-10-03 1995-04-04 1995-10-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag